ValuEngine Upgrades Monmouth R.E. Inv. (NYSE:MNR) to “Hold”

Share on StockTwits

Monmouth R.E. Inv. (NYSE:MNR) was upgraded by ValuEngine from a “sell” rating to a “hold” rating in a report issued on Wednesday, October 17th.

Several other research firms have also recently weighed in on MNR. Boenning Scattergood reaffirmed a “buy” rating and set a $19.00 price objective on shares of Monmouth R.E. Inv. in a research report on Friday, September 7th. Zacks Investment Research raised Monmouth R.E. Inv. from a “hold” rating to a “buy” rating and set a $19.00 price target for the company in a research report on Tuesday, July 17th. Finally, B. Riley raised Monmouth R.E. Inv. from a “neutral” rating to a “buy” rating and reduced their price target for the company from $17.50 to $17.00 in a research report on Tuesday, October 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $18.60.

Shares of MNR stock traded down $0.07 on Wednesday, hitting $14.94. 325,260 shares of the stock were exchanged, compared to its average volume of 651,499. The company has a debt-to-equity ratio of 1.59, a current ratio of 5.61 and a quick ratio of 5.61. The stock has a market capitalization of $1.21 billion, a P/E ratio of 19.66, a P/E/G ratio of 2.12 and a beta of 0.67. Monmouth R.E. Inv. has a fifty-two week low of $13.87 and a fifty-two week high of $18.45.

In other Monmouth R.E. Inv. news, insider Umh Properties, Inc. acquired 9,396 shares of the business’s stock in a transaction dated Monday, September 17th. The stock was bought at an average cost of $16.39 per share, with a total value of $154,000.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Eugene W. Landy sold 8,000 shares of the stock in a transaction that occurred on Wednesday, August 15th. The stock was sold at an average price of $16.84, for a total value of $134,720.00. Following the transaction, the chairman now owns 852,776 shares in the company, valued at approximately $14,360,747.84. The disclosure for this sale can be found here. Over the last ninety days, insiders bought 12,414 shares of company stock valued at $201,001. Insiders own 4.63% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in MNR. Hsbc Holdings PLC bought a new position in shares of Monmouth R.E. Inv. during the first quarter worth approximately $173,000. Cubist Systematic Strategies LLC bought a new position in Monmouth R.E. Inv. during the 1st quarter worth $174,000. Amalgamated Bank bought a new position in Monmouth R.E. Inv. during the 2nd quarter worth $175,000. Campbell & CO Investment Adviser LLC bought a new position in Monmouth R.E. Inv. during the 2nd quarter worth $180,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Monmouth R.E. Inv. during the 2nd quarter worth $183,000. Institutional investors own 62.69% of the company’s stock.

Monmouth R.E. Inv. Company Profile

Monmouth Real Estate Investment Corporation, founded in 1968, is one of the oldest public equity REITs in the world. The Company specializes in single tenant, net-leased industrial properties, subject to long-term leases, primarily to investment-grade tenants. Monmouth Real Estate is a fully-integrated and self-managed real estate company, whose property portfolio consists of 109 properties containing a total of approximately 20.5 million rentable square feet, geographically diversified across 30 states.

See Also: Inflation

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Monmouth R.E. Inv. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monmouth R.E. Inv. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.